| Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis NFS Watson, JM Ramage, Z Madjd, I Spendlove, IO Ellis, JH Scholefield, ... International journal of cancer 118 (1), 6-10, 2006 | 328 | 2006 |
| Expression of the stress‐related MHC class I chain‐related protein MICA is an indicator of good prognosis in colorectal cancer patients NFS Watson, I Spendlove, Z Madjd, R McGilvray, AR Green, IO Ellis, ... International journal of cancer 118 (6), 1445-1452, 2006 | 211 | 2006 |
| Total loss of MHC class I is an independent indicator of good prognosis in breast cancer Z Madjd, I Spendlove, SE Pinder, IO Ellis, LG Durrant International journal of cancer 117 (2), 248-255, 2005 | 188 | 2005 |
| CD44+ cancer cells express higher levels of the anti-apoptotic protein Bcl-2 in breast tumours Z Madjd, A Zare Mehrjerdi, AM Sharifi, S Molanaei, SZ Shahzadi, ... Cancer immunity 9 (1), 2009 | 144 | 2009 |
| High expression of Lewisy/bantigens is associated with decreased survival in lymph node negative breast carcinomas Z Madjd, T Parsons, NFS Watson, I Spendlove, I Ellis, LG Durrant Breast Cancer Research 7, 1-8, 2005 | 129 | 2005 |
| The ubiquitin-binding protein p62 is expressed in breast cancers showing features of aggressive disease P Rolland, Z Madjd, L Durrant, IO Ellis, R Layfield, I Spendlove Endocrine-related cancer 14 (1), 73-80, 2007 | 128 | 2007 |
| Tumor-derived exosomes: the next generation of promising cell-free vaccines in cancer immunotherapy M Naseri, M Bozorgmehr, M Zöller, E Ranaei Pirmardan, Z Madjd Oncoimmunology 9 (1), 1779991, 2020 | 127 | 2020 |
| Apelin-13 protects the brain against ischemic reperfusion injury and cerebral edema in a transient model of focal cerebral ischemia M Khaksari, N Aboutaleb, F Nasirinezhad, A Vakili, Z Madjd Journal of Molecular Neuroscience 48, 201-208, 2012 | 107 | 2012 |
| Co-expression of cancer stem cell markers OCT4 and NANOG predicts poor prognosis in renal cell carcinomas A Rasti, M Mehrazma, Z Madjd, M Abolhasani, L Saeednejad Zanjani, ... Scientific reports 8 (1), 11739, 2018 | 106 | 2018 |
| Upregulation of MICA on high-grade invasive operable breast carcinoma Z Madjd, I Spendlove, R Moss, S Bevin, SE Pinder, NFS Watson, I Ellis, ... Cancer immunity 7 (1), 2007 | 103 | 2007 |
| Morphological and molecular characteristics of spheroid formation in HT-29 and Caco-2 colorectal cancer cell lines E Gheytanchi, M Naseri, F Karimi-Busheri, F Atyabi, ES Mirsharif, ... Cancer cell international 21, 1-16, 2021 | 102 | 2021 |
| Expression of the membrane complement regulatory protein CD59 (protectin) is associated with reduced survival in colorectal cancer patients NFS Watson, LG Durrant, Z Madjd, IO Ellis, JH Scholefield, I Spendlove Cancer Immunology, Immunotherapy 55, 973-980, 2006 | 97 | 2006 |
| Differential expression of cancer stem cell markers ALDH1 and CD133 in various lung cancer subtypes R Roudi, A Korourian, A Shariftabrizi, Z Madjd Cancer investigation 33 (7), 294-302, 2015 | 95 | 2015 |
| 3D protein-based bilayer artificial skin for the guided scarless healing of third-degree burn wounds in vivo M Gholipourmalekabadi, AM Seifalian, AM Urbanska, MD Omrani, ... Biomacromolecules 19 (7), 2409-2422, 2018 | 86 | 2018 |
| Occult hepatitis C virus infection in Iranian patients with cryptogenic liver disease F Bokharaei‐Salim, H Keyvani, SHR Monavari, SM Alavian, Z Madjd, ... Journal of Medical Virology 83 (6), 989-995, 2011 | 83 | 2011 |
| Loss of CD59 expression in breast tumours correlates with poor survival Z Madjd, SE Pinder, C Paish, IO Ellis, J Carmichael, LG Durrant The Journal of Pathology: A Journal of the Pathological Society of Great …, 2003 | 82 | 2003 |
| Exosomes derived from miR-34a-overexpressing mesenchymal stem cells inhibit in vitro tumor growth: A new approach for drug delivery F Vakhshiteh, S Rahmani, SN Ostad, Z Madjd, R Dinarvand, F Atyabi Life Sciences 266, 118871, 2021 | 79 | 2021 |
| ALDH1 in combination with CD44 as putative cancer stem cell markers are correlated with poor prognosis in urothelial carcinoma of the urinary bladder H Keymoosi, E Gheytanchi, M Asgari, A Shariftabrizi, Z Madjd Asian Pacific Journal of Cancer Prevention 15 (5), 2013-2020, 2014 | 77 | 2014 |
| The p53 Positive Bcl-2 Negative Phenotype is an independent marker of prognosis in breast cancer P Rolland, I Spendlove, Z Madjd, EA Rakha, P Poulam, IO Ellis, L Durrant International J Cancer 120 (6), 1311-7, 2006 | 76 | 2006 |
| Periostin: biology and function in cancer S Dorafshan, M Razmi, S Safaei, E Gentilin, Z Madjd, R Ghods Cancer Cell International 22 (1), 315, 2022 | 68 | 2022 |
Ahmad ShariftabriziUniversity of IowaVerifierad e-postadress på healthcare.uiowa.edu